tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TNYA Stock Latest News

Tenaya Therapeutics Reports Improved Financials Amid Strategic Focus
Company AnnouncementsTenaya Therapeutics Reports Improved Financials Amid Strategic Focus
14d ago
TNYA
Promising Outlook for Tenaya Therapeutics’ TN-201 Program Despite Procedural Clinical Hold
PremiumRatings
Promising Outlook for Tenaya Therapeutics’ TN-201 Program Despite Procedural Clinical Hold
14d ago
TNYA
Tenaya Therapeutics reports Q3 EPS (12c), consensus (15c)
PremiumThe Fly
Tenaya Therapeutics reports Q3 EPS (12c), consensus (15c)
15d ago
TNYA
Promising Clinical Developments and Regulatory Optimism Drive Buy Rating for Tenaya Therapeutics
PremiumRatings
Promising Clinical Developments and Regulatory Optimism Drive Buy Rating for Tenaya Therapeutics
15d ago
TNYA
Tenaya Therapeutics presents new interim safety, efficacy data on TN-201
PremiumThe Fly
Tenaya Therapeutics presents new interim safety, efficacy data on TN-201
15d ago
TNYA
FDA Places Hold on Tenaya’s MyPEAKTM-1 Trial
PremiumCompany AnnouncementsFDA Places Hold on Tenaya’s MyPEAKTM-1 Trial
17d ago
8K
TNYA
Promising Developments in Tenaya Therapeutics’ MyPEAK-1 Study Support Buy Rating
Premium
Ratings
Promising Developments in Tenaya Therapeutics’ MyPEAK-1 Study Support Buy Rating
20d ago
TNYA
Tenaya Therapeutics Advances Genetic Therapy for Heart Disease: A Closer Look at the TN-201 Study
Premium
Company Announcements
Tenaya Therapeutics Advances Genetic Therapy for Heart Disease: A Closer Look at the TN-201 Study
28d ago
TNYA
Tenaya Therapeutics Advances Gene Therapy Study for ARVC
PremiumCompany Announcements
Tenaya Therapeutics Advances Gene Therapy Study for ARVC
28d ago
TNYA
Tenaya Therapeutics Advances Pediatric Cardiomyopathy Research with New Study Update
PremiumCompany Announcements
Tenaya Therapeutics Advances Pediatric Cardiomyopathy Research with New Study Update
28d ago
TNYA
Tenaya Therapeutics’ ARVC Study: A Closer Look at AAV9 Antibody Prevalence
PremiumCompany Announcements
Tenaya Therapeutics’ ARVC Study: A Closer Look at AAV9 Antibody Prevalence
28d ago
TNYA
Tenaya Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Tenaya Therapeutics management to meet with Piper Sandler
1M ago
TNYA
Promising Developments and Strategic Approaches in Tenaya Therapeutics’ Gene Therapy Programs Drive Buy Rating
PremiumRatingsPromising Developments and Strategic Approaches in Tenaya Therapeutics’ Gene Therapy Programs Drive Buy Rating
3M ago
TNYA
Promising Potential of Tenaya Therapeutics’ TN-201 Gene Therapy in Addressing Pediatric Hypertrophic Cardiomyopathy: Analyst Recommends Buy
Premium
Ratings
Promising Potential of Tenaya Therapeutics’ TN-201 Gene Therapy in Addressing Pediatric Hypertrophic Cardiomyopathy: Analyst Recommends Buy
3M ago
TNYA
Tenaya Therapeutics presents interim data from MyClimb natural history study
Premium
The Fly
Tenaya Therapeutics presents interim data from MyClimb natural history study
3M ago
TNYA
Promising Advancements and Strategic Approaches Underpin Buy Rating for Tenaya Therapeutics
PremiumRatings
Promising Advancements and Strategic Approaches Underpin Buy Rating for Tenaya Therapeutics
3M ago
TNYA
Innovative Cardiac Gene Therapy Drives Buy Rating for Tenaya Therapeutics
PremiumRatings
Innovative Cardiac Gene Therapy Drives Buy Rating for Tenaya Therapeutics
3M ago
TNYA
Innovative Cardiac Gene Therapy Advances: Tenaya Therapeutics’ Strategic Developments and Analyst Confidence
PremiumRatings
Innovative Cardiac Gene Therapy Advances: Tenaya Therapeutics’ Strategic Developments and Analyst Confidence
3M ago
TNYA
Innovative Gene Therapy Advancements: Tenaya Therapeutics’ Breakthrough in Protein Expression Measurement
PremiumRatings
Innovative Gene Therapy Advancements: Tenaya Therapeutics’ Breakthrough in Protein Expression Measurement
3M ago
TNYA
Tenaya Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsTenaya Therapeutics Reports Q2 2025 Financial Results
3M ago
TNYA
Buy Rating for Tenaya Therapeutics: Financial Stability and Promising Clinical Trial Results
Premium
Ratings
Buy Rating for Tenaya Therapeutics: Financial Stability and Promising Clinical Trial Results
4M ago
TNYA
Promising Developments and Strong Financial Position Drive Buy Rating for Tenaya Therapeutics
Premium
Ratings
Promising Developments and Strong Financial Position Drive Buy Rating for Tenaya Therapeutics
4M ago
TNYA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >